+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Lateral Flow Assays Market by Product Type, Application, End User, Sample Type, Readout Type, Material, Format - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5470924
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Lateral Flow Assays Market grew from USD 10.03 billion in 2024 to USD 10.48 billion in 2025. It is expected to continue growing at a CAGR of 4.37%, reaching USD 12.97 billion by 2030.

Shaping the Future of Diagnostics with Lateral Flow Assays

Lateral flow assays have emerged as a cornerstone of rapid, user-friendly diagnostics, offering real-time insights at the point of care across a broad spectrum of applications. From detecting infectious pathogens to monitoring chronic conditions, these tests marry simplicity with sensitivity, empowering clinicians, patients, and researchers alike. The global health ecosystem’s increasing emphasis on decentralization and immediate decision-making has propelled the adoption of lateral flow assays, cementing their role in modern healthcare.

This executive summary distills pivotal developments shaping the lateral flow assay market, furnishing decision-makers with a clear understanding of transformative trends, regulatory headwinds, and strategic imperatives. By examining shifts in technological paradigms, the implications of new trade policies, and nuanced segmentation patterns, this overview provides a robust foundation for steering investment and innovation.

Subsequent sections explore how evolving market forces intersect with diverse product and end-user landscapes, regional dynamics, and competitive pressures. Through a cohesive, data-driven narrative, readers will gain actionable insights to navigate complexities, capitalize on emerging opportunities, and maintain a competitive edge in the rapidly advancing diagnostic arena.

Key Shifts Redefining the Lateral Flow Assay Landscape

The lateral flow assay landscape is undergoing seismic shifts as new materials, digital integration, and point-of-care connectivity redefine traditional paradigms. Advanced nitrocellulose membranes and novel binding chemistries now deliver enhanced sensitivity and multiplexing capabilities, while miniaturized readers leverage electrochemical and fluorescence detection to expand quantitative analysis beyond visual interpretation.

Simultaneously, the integration of smartphone-based imaging and cloud analytics is unlocking remote monitoring and real-time data aggregation, transforming standalone tests into connected devices within telehealth ecosystems. Post-pandemic imperatives have further accelerated demand for decentralized testing platforms, prompting manufacturers to streamline production and adopt modular designs that support rapid reconfiguration for emerging threats.

Amid these technological advances, regulatory frameworks are evolving to accommodate novel diagnostics, with expedited pathways for emergency use authorizations and digital health approvals. At the same time, heightened scrutiny on quality and reproducibility is driving investment in standardized manufacturing processes and robust supply chain resilience. These concurrent developments are reshaping competitive dynamics, compelling stakeholders to innovate across the value chain and forge strategic alliances to maintain relevance in an increasingly complex marketplace.

Assessing the Impact of 2025 US Tariffs on Lateral Flow Assays

The introduction of new United States tariffs in 2025 on raw materials and finished diagnostic devices has introduced a layer of complexity for lateral flow assay manufacturers. By targeting imported cellulose, specialty membranes, and select reagents, these measures have elevated input costs, triggering a reassessment of global sourcing strategies and production footprints.

As a result, many industry players are exploring near-shoring options, establishing localized manufacturing hubs to mitigate tariff exposure and strengthen supply security. Strategic partnerships with regional suppliers have emerged as a pragmatic approach to maintain cost competitiveness while preserving quality standards. Simultaneously, some organizations are absorbing a portion of the cost increases, leveraging scale efficiencies and long-term contracts to stabilize pricing for end users.

Although short-term margin pressures have surfaced, the tariff environment is also catalyzing innovation in material science and process optimization. Manufacturers are trialing alternative substrates and adhesive formulations to reduce reliance on tariff-affected imports. These adaptive strategies are poised to deliver long-term benefits in cost structure and supply chain agility, ensuring that the lateral flow assay sector remains resilient despite evolving trade policies.

Deep Dive into Market Segmentation Dynamics

An in-depth segmentation analysis reveals the multifaceted nature of the lateral flow assay market. When examined by product type, cardiac markers continue to dominate due to the rising prevalence of cardiovascular disease, while assays for infectious diseases spanning hepatitis, HIV, influenza, and malaria have surged in response to global health initiatives. Simultaneously, the market for drugs of abuse and pregnancy tests maintains steady growth driven by regulatory compliance and consumer convenience.

Application-based segmentation highlights how clinical diagnostics remains the largest revenue contributor, yet environmental testing and food safety are capturing increased attention as regulatory bodies heighten screening requirements. Quality control laboratories deploy lateral flow formats to streamline in-process monitoring, and veterinary testing benefits from the portability and rapid turnaround time of cassette and strip designs.

End-user dynamics underscore the diverse deployment settings: diagnostic laboratories leverage high-throughput well plates for batch testing, hospitals and clinics rely on point-of-care formats across primary, secondary, and tertiary centers, and home care enables patient-administered testing with simplified colorimetric readouts. Research institutes further exploit electrochemical and fluorescence detection to pioneer next-generation assay chemistries.

Sample type considerations shape kit design, with saliva, serum and plasma, urine, and whole blood protocols tailored to specific use cases. The choice of readout-whether colorimetric, electrochemical, fluorescence, or luminescent-drives investments in reader development. Meanwhile, material innovations in cellulose, glass fiber, nitrocellulose membrane, and polyester substrates align with format choices spanning cassettes, strips, and well plates, each optimized for distinct throughput and sensitivity requirements.

Regional Variations Driving Assay Adoption

Regional insights illuminate how geographical nuances influence market growth and adoption patterns. In the Americas, expansive healthcare infrastructure and strong reimbursement frameworks have fueled rapid uptake of lateral flow assays, particularly for cardiovascular and infectious disease screening. Domestic manufacturing capabilities and robust distribution networks further enhance market responsiveness.

Across Europe, the Middle East, and Africa, varying regulatory pathways and economic landscapes create differentiated opportunities. Western European nations emphasize stringent quality standards and digital integration, while emerging markets in the Middle East and Africa exhibit growing demand for cost-effective, decentralized testing solutions amid evolving public health priorities.

The Asia-Pacific region stands out for its dynamic growth trajectory, driven by rising healthcare investment in China, India, and Southeast Asia. Government-led initiatives to expand rural diagnostics, coupled with local production incentives, have propelled the development of indigenous lateral flow platforms. Collaborative ventures between regional firms and global players are accelerating technology transfer and capacity expansion, positioning Asia-Pacific as a key growth engine for the industry.

Competitive Landscape and Leading Innovators

Competitive intensity in the lateral flow assay space is anchored by established diagnostics giants and agile innovators alike. Leading global manufacturers continue to invest heavily in research and development, expanding their portfolios through acquisitions and strategic alliances. These firms capitalize on their scale to negotiate favorable supply terms and maintain broad distribution channels across clinical and commercial segments.

Emerging companies are differentiating through niche applications and specialized materials, introducing novel reader platforms that harness electrochemical and fluorescence detection for enhanced quantitative performance. Several mid-tier organizations have carved out market share by focusing on environmental and food safety testing, leveraging partnerships with regulatory bodies to validate their assays for stringent compliance requirements.

Additionally, cross-sector collaborations are on the rise, as technology firms integrate data analytics and artificial intelligence into assay workflows to deliver predictive insights and remote monitoring capabilities. This convergence of diagnostics and digital health is redefining competitive benchmarks, compelling all players to broaden their value propositions beyond standalone tests.

Strategic Imperatives for Industry Leadership

Industry leaders must embrace a multipronged strategy to thrive in the evolving lateral flow assay market. Prioritizing investment in next-generation membrane technologies and advanced conjugate chemistries will drive performance improvements and differentiation. Concurrently, integrating digital readers and cloud-based analytics into assay platforms will unlock new revenue streams in telehealth and remote monitoring.

Supply chain diversification remains critical; organizations should cultivate relationships with regional suppliers and explore manufacturing partnerships to mitigate trade policy risks. Developing modular production lines that can pivot swiftly between different assay formats will enhance responsiveness to emergent health threats and regulatory changes.

Collaboration is equally vital. Engaging in cross-industry consortia and public-private partnerships can accelerate assay validation, expedite emergency use authorizations, and foster co-development of novel applications. Finally, targeted expansion into underserved regions-with tailored pricing models and distribution strategies-will drive broader market penetration and establish early-mover advantages in high-growth markets.

Rigorous Approach to Research and Analysis

This research employed a rigorous, multi-step methodology to ensure accuracy and relevance. Initially, a comprehensive review of public filings, regulatory databases, and scientific literature established the foundational understanding of market trajectories and technological advancements. Subsequently, in-depth interviews were conducted with key stakeholders, including diagnostic developers, regulatory experts, and supply chain managers, to capture nuanced perspectives on operational challenges and strategic priorities.

Quantitative data collection encompassed proprietary surveys distributed to global end users across clinical diagnostics, environmental testing, food safety, veterinary testing, and academic research. Responses were triangulated with third-party databases and validated through statistical analysis to identify prevailing trends and outliers.

Finally, iterative synthesis workshops involving internal analysts and external advisors refined the insights, ensuring coherence and actionable relevance. Throughout this process, adherence to stringent quality control protocols preserved data integrity and minimized bias, resulting in a robust, evidence-based assessment of the lateral flow assay market.

Consolidating Insights for Informed Decisions

The trajectory of lateral flow assays reflects a confluence of innovation, regulatory evolution, and shifting market dynamics. Advanced materials and digital integration are unlocking fresh opportunities, while new trade policies underscore the importance of strategic supply chain management. Regional variations further accentuate the need for tailored approaches that align with local healthcare infrastructures and regulatory environments.

By synthesizing segmentation insights across product types, applications, end-user settings, sample matrices, readout technologies, materials, and formats, stakeholders can pinpoint high-value niches and optimize resource allocation. The competitive landscape, marked by collaboration between diagnostics and digital health specialists, signals an era where data-driven decision-making and remote connectivity will define market leaders.

Ultimately, those organizations that proactively embrace material innovation, diversify manufacturing footprints, and forge collaborative partnerships will be best positioned to capitalize on the expanding lateral flow assay market. The insights presented herein equip decision-makers with the clarity needed to navigate complexity and secure sustainable growth.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Cardiac Marker
    • COVID-19
    • Drugs Of Abuse
    • Infectious Disease
      • Hepatitis
      • Hiv
      • Influenza
      • Malaria
    • Pregnancy
  • Application
    • Clinical Diagnostics
    • Environmental Testing
    • Food Safety
    • Quality Control
    • Veterinary Testing
  • End User
    • Diagnostic Laboratories
    • Home Care
    • Hospitals & Clinics
      • Primary Care Centers
      • Secondary Hospitals
      • Tertiary Hospitals
    • Point Of Care Testing
    • Research Institutes
  • Sample Type
    • Saliva
    • Serum & Plasma
    • Urine
    • Whole Blood
  • Readout Type
    • Colorimetric
    • Electrochemical
    • Fluorescence
    • Luminescent
  • Material
    • Cellulose
    • Glass Fiber
    • Nitrocellulose Membrane
    • Polyester
  • Format
    • Cassette
    • Strip
    • Well Plate
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Abbott Laboratories
  • Roche Diagnostics International AG
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Quidel Corporation
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Hologic, Inc.
  • Meridian Bioscience, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Lateral Flow Assays Market, by Product Type
8.1. Introduction
8.2. Cardiac Marker
8.3. COVID-19
8.4. Drugs of Abuse
8.5. Infectious Disease
8.5.1. Hepatitis
8.5.2. Hiv
8.5.3. Influenza
8.5.4. Malaria
8.6. Pregnancy
9. Lateral Flow Assays Market, by Application
9.1. Introduction
9.2. Clinical Diagnostics
9.3. Environmental Testing
9.4. Food Safety
9.5. Quality Control
9.6. Veterinary Testing
10. Lateral Flow Assays Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Home Care
10.4. Hospitals & Clinics
10.4.1. Primary Care Centers
10.4.2. Secondary Hospitals
10.4.3. Tertiary Hospitals
10.5. Point of Care Testing
10.6. Research Institutes
11. Lateral Flow Assays Market, by Sample Type
11.1. Introduction
11.2. Saliva
11.3. Serum & Plasma
11.4. Urine
11.5. Whole Blood
12. Lateral Flow Assays Market, by Readout Type
12.1. Introduction
12.2. Colorimetric
12.3. Electrochemical
12.4. Fluorescence
12.5. Luminescent
13. Lateral Flow Assays Market, by Material
13.1. Introduction
13.2. Cellulose
13.3. Glass Fiber
13.4. Nitrocellulose Membrane
13.5. Polyester
14. Lateral Flow Assays Market, by Format
14.1. Introduction
14.2. Cassette
14.3. Strip
14.4. Well Plate
15. Americas Lateral Flow Assays Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Lateral Flow Assays Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Lateral Flow Assays Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Abbott Laboratories
18.3.2. Roche Diagnostics International AG
18.3.3. Becton, Dickinson and Company
18.3.4. Thermo Fisher Scientific Inc.
18.3.5. Siemens Healthineers AG
18.3.6. Quidel Corporation
18.3.7. Danaher Corporation
18.3.8. Bio-Rad Laboratories, Inc.
18.3.9. Hologic, Inc.
18.3.10. Meridian Bioscience, Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. LATERAL FLOW ASSAYS MARKET MULTI-CURRENCY
FIGURE 2. LATERAL FLOW ASSAYS MARKET MULTI-LANGUAGE
FIGURE 3. LATERAL FLOW ASSAYS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2024 VS 2030 (%)
FIGURE 20. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. LATERAL FLOW ASSAYS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. LATERAL FLOW ASSAYS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. LATERAL FLOW ASSAYS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY CARDIAC MARKER, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY COVID-19, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY DRUGS OF ABUSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY HIV, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY MALARIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY PREGNANCY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY FOOD SAFETY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY VETERINARY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY PRIMARY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SECONDARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY SERUM & PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY COLORIMETRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY ELECTROCHEMICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY FLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY LUMINESCENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY GLASS FIBER, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY NITROCELLULOSE MEMBRANE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY POLYESTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY CASSETTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY STRIP, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY WELL PLATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES LATERAL FLOW ASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 72. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 74. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 77. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 78. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 79. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 80. CANADA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 81. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 83. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 86. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 87. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 88. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 89. MEXICO LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 127. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 129. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 132. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 133. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 134. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 135. GERMANY LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 136. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 138. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 141. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 142. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 143. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 144. FRANCE LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 154. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 156. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 159. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 160. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 161. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 162. ITALY LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 163. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 168. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 169. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 170. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 171. SPAIN LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 190. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 199. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 201. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 204. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 205. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 206. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 207. DENMARK LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 213. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 214. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 215. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 216. NETHERLANDS LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 217. QATAR LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. QATAR LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 219. QATAR LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. QATAR LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. QATAR LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 222. QATAR LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 223. QATAR LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 224. QATAR LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 225. QATAR LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 226. FINLAND LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. FINLAND LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 228. FINLAND LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. FINLAND LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. FINLAND LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 231. FINLAND LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 232. FINLAND LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 233. FINLAND LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 234. FINLAND LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 235. SWEDEN LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. SWEDEN LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 237. SWEDEN LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. SWEDEN LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. SWEDEN LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 240. SWEDEN LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 241. SWEDEN LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 242. SWEDEN LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 243. SWEDEN LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 246. NIGERIA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. NIGERIA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. NIGERIA LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 249. NIGERIA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 250. NIGERIA LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 251. NIGERIA LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 252. NIGERIA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 253. EGYPT LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. EGYPT LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 255. EGYPT LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. EGYPT LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. EGYPT LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 258. EGYPT LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 259. EGYPT LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 260. EGYPT LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 261. EGYPT LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 262. TURKEY LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. TURKEY LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 264. TURKEY LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. TURKEY LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. TURKEY LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 267. TURKEY LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 268. TURKEY LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 269. TURKEY LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 270. TURKEY LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. ISRAEL LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 276. ISRAEL LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 277. ISRAEL LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 278. ISRAEL LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 279. ISRAEL LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 280. NORWAY LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 281. NORWAY LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 282. NORWAY LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. NORWAY LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. NORWAY LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 285. NORWAY LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 286. NORWAY LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 287. NORWAY LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 288. NORWAY LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 289. POLAND LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 290. POLAND LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 291. POLAND LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. POLAND LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. POLAND LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 294. POLAND LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 295. POLAND LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 296. POLAND LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 297. POLAND LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 305. SWITZERLAND LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 306. SWITZERLAND LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 307. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 308. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 309. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 312. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 313. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 314. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 315. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 316. ASIA-PACIFIC LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 317. CHINA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 318. CHINA LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 319. CHINA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. CHINA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. CHINA LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 322. CHINA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 323. CHINA LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 324. CHINA LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 325. CHINA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 326. INDIA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 327. INDIA LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 328. INDIA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 329. INDIA LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 330. INDIA LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 331. INDIA LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 332. INDIA LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 333. INDIA LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 334. INDIA LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 335. JAPAN LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 336. JAPAN LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 337. JAPAN LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 338. JAPAN LATERAL FLOW ASSAYS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 339. JAPAN LATERAL FLOW ASSAYS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 340. JAPAN LATERAL FLOW ASSAYS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 341. JAPAN LATERAL FLOW ASSAYS MARKET SIZE, BY READOUT TYPE, 2018-2030 (USD MILLION)
TABLE 342. JAPAN LATERAL FLOW ASSAYS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 343. JAPAN LATERAL FLOW ASSAYS MARKET SIZE, BY FORMAT, 2018-2030 (USD MILLION)
TABLE 344. AUSTRALIA LATERAL FLOW ASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 345. AUSTRALIA LATERAL FLOW ASSAYS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 346. AUSTRALIA LATERAL FLOW ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 347. AUSTRALIA LATERA

Companies Mentioned

The companies profiled in this Lateral Flow Assays market report include:
  • Abbott Laboratories
  • Roche Diagnostics International AG
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Quidel Corporation
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Hologic, Inc.
  • Meridian Bioscience, Inc.

Methodology

Loading
LOADING...

Table Information